A new approach to vessel dilatation is long overdue for treatment of diseased peripheral arteries. Today, we are treating more complex lesions that require better tools. We believe Serration Technology is effective in treating these complex lesions and will evolve into the new standard of care for vessel dilatation.

I have been very impressed with the luminal gain that can be achieved at low atmospheric pressures provided by serration angioplasty, even in heavily calcified vessels. In addition, the luminal gain in the setting of minimal dissection, and less vessel recoil than POBA, makes this a very compelling new tool for BTK disease.